Other OTC Pharmaceuticals (Pharmacies) - North Macedonia

  • North Macedonia
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$8.59m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.80%, resulting in a market volume of US$8.94m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$4.12 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in North Macedonia is experiencing significant growth and development.

Customer preferences:
Customers in North Macedonia have shown a strong preference for over-the-counter (OTC) pharmaceutical products. This preference can be attributed to several factors. Firstly, OTC products are easily accessible and do not require a prescription, making them convenient for customers who prefer self-medication. Additionally, OTC products are often more affordable compared to prescription medications, making them an attractive option for cost-conscious consumers. Finally, the wide availability of OTC products in pharmacies across the country allows customers to easily find the products they need.

Trends in the market:
One of the key trends in the Other OTC Pharmaceuticals (Pharmacies) market in North Macedonia is the increasing demand for preventive healthcare products. Customers are becoming more proactive in taking care of their health and are seeking products that can help prevent illnesses and promote overall well-being. This trend is driven by a growing awareness of the importance of preventive measures, such as maintaining a healthy lifestyle and using OTC products to address minor health issues before they escalate. Another trend in the market is the rising popularity of natural and herbal remedies. Customers are increasingly turning to alternative medicine and natural products for their healthcare needs. This trend can be attributed to a growing preference for holistic approaches to health and wellness. Customers are seeking OTC products that are perceived to be more natural and have fewer side effects compared to conventional pharmaceuticals.

Local special circumstances:
North Macedonia has a well-established network of pharmacies, making OTC products easily accessible to the population. This accessibility is further enhanced by the fact that pharmacies are often located in close proximity to residential areas and have extended operating hours. This allows customers to conveniently purchase OTC products whenever they need them.

Underlying macroeconomic factors:
The growth of the Other OTC Pharmaceuticals (Pharmacies) market in North Macedonia can be attributed to several macroeconomic factors. Firstly, the country has experienced steady economic growth in recent years, resulting in an increase in disposable income. This has allowed customers to spend more on healthcare products, including OTC pharmaceuticals. Furthermore, the government of North Macedonia has implemented policies to improve healthcare access and affordability. This has led to an increase in the overall demand for healthcare products, including OTC pharmaceuticals. The government's focus on improving healthcare infrastructure and services has also contributed to the growth of the market. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in North Macedonia is developing due to customer preferences for accessible and affordable healthcare products, the increasing demand for preventive healthcare products, and the rising popularity of natural and herbal remedies. The local special circumstances, such as the well-established network of pharmacies and extended operating hours, further contribute to the growth of the market. Additionally, underlying macroeconomic factors, such as steady economic growth and government policies to improve healthcare access, play a significant role in driving the development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)